Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome

CONTEXT: Patients with von Hippel-Lindau (VHL) syndrome have a 25–30% chance of developing pheochromocytoma. Although practice guidelines recommend biochemical and radiological screening every 1–2 years for pheochromocytoma in patients with VHL, there are limited data on the optimal age and frequenc...

詳細記述

保存先:
書誌詳細
出版年:J Clin Endocrinol Metab
主要な著者: Aufforth, Rachel D., Ramakant, Pooja, Sadowski, Samira M., Mehta, Amit, Trebska-McGowan, Katarzyna, Nilubol, Naris, Pacak, Karel, Kebebew, Electron
フォーマット: Artigo
言語:Inglês
出版事項: Endocrine Society 2015
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4667160/
https://ncbi.nlm.nih.gov/pubmed/26451910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-3045
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料